Cash · 2011–2025
Neurocrine Biosciences cash
$713M+206.0% · FY2025
Neurocrine Biosciences (NBIX) reported $713M in cash for fiscal 2025, +206.0% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $713M | +206.0% | Open → |
| FY20242024-12-31 | $233M | −7.2% | Open → |
| FY20232023-12-31 | $251M | −4.5% | Open → |
| FY20222022-12-31 | $263M | −22.9% | Open → |
| FY20212021-12-31 | $341M | +82.1% | Open → |
| FY20202020-12-31 | $187M | +66.6% | Open → |
| FY20192019-12-31 | $112M | −20.8% | Open → |
| FY20182018-12-31 | $142M | −44.4% | Open → |
| FY20172017-12-31 | $255M | +205.9% | Open → |
| FY20162016-12-31 | $83.3M | +12.2% | Open → |
| FY20152015-12-31 | $74.2M | +139.2% | Open → |
| FY20142014-12-31 | $31.0M | −30.8% | Open → |
| FY20132013-12-31 | $44.8M | −29.7% | Open → |
| FY20122012-12-31 | $63.8M | +27.2% | Open → |
| FY20112011-12-31 | $50.1M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +20.9%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neurocrine Biosciences cash |url=https://companiesranked.com/en/company/neurocrine-biosciences/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neurocrine Biosciences cash. CompaniesRanked. https://companiesranked.com/en/company/neurocrine-biosciences/cash-on-handBibTeX
@misc{companiesranked-en-company-neurocrine-biosciences-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Neurocrine Biosciences cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neurocrine-biosciences/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000914475-26-000037 · July 31, 2026
{{cite web |title=Neurocrine Biosciences cash — 10-Q (0000914475-26-000037) |url=https://www.sec.gov/Archives/edgar/data/914475/000091447526000037/nbix-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-31}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.